cancer vacines

Oncology

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science off

News

New data from GSK's BEHOLD-1 study of B7-H4-targeted ADC mo-rez reinforce earlier results in platinum-resistant ovarian cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.